ArticleCancer science2007

Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand.

Satoru Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.